88 results on '"Iversen, Lars"'
Search Results
2. Drivers and effects of construction-sand mining in Sub-Saharan Africa
3. Prioritizing taxa for genetic reference database development to advance inland water conservation
4. Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)
5. Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureus and Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma
6. Global change and plant-ecosystem functioning in freshwaters
7. 33884 Complete skin clearance for patients with moderate to severe plaque psoriasis: The relationship between improvements in Psoriasis Area and Severity Index and health-related quality of life
8. Towards linking freshwater plants and ecosystems via functional biogeography
9. Maintien de la réponse par bimékizumab jusqu’à 1 an chez des patients présentant un psoriasis en plaques modéré à sévère : résultats groupés de trois études de phase 3
10. Sand, gravel, and UN Sustainable Development Goals: Conflicts, synergies, and pathways forward
11. miRNA signature in early-stage mycosis fungoides
12. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma
13. 26581 Maintenance of complete skin clearance throughout 3 years of continuous guselkumab treatment in patients with moderate-to-severe psoriasis: A post hoc analysis of 5-year data from the VOYAGE 1 trial
14. 26580 Efficacy of treatment with brodalumab after treatment failure of previous interleukin 17A inhibitors in patients with psoriasis
15. 26874 Long-term efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who were partial responders or nonresponders to etanercept: Post hoc analysis through 5 years from the reSURFACE 2 phase 3 trial
16. Rarity in freshwater vascular plants across Europe and North America: Patterns, mechanisms and future scenarios
17. 27383 Bimekizumab response maintenance up to 1 year in patients with moderate to severe plaque psoriasis: Pooled results from three phase 3 trials
18. Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatment
19. Diagnostic Two-Gene Classifier in Early-Stage Mycosis Fungoides: A Retrospective Multicenter Study
20. 13634 Tildrakizumab provides early predictability of response in patients with moderate to severe psoriasis: Results from reSURFACE 1 and reSURFACE 2 phase 3 trials
21. 15807 Efficacy of tildrakizumab in patients with moderate to severe psoriasis according to disease duration: Pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials at week 28
22. 14159 Sustained improvements in itch, skin pain, and health-related quality of life through 5 years of treatment with ixekizumab in patients with moderate to severe plaque psoriasis
23. IκBζ is a key player in the antipsoriatic effects of secukinumab
24. Drivers of net methane uptake across Greenlandic dry heath tundra landscapes
25. Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma
26. Prognostic miRNA classifier in early-stage mycosis fungoides: Development and validation in a Danish nationwide study
27. Differences in the miRNA expression profiles of erythrodermic mycosis fungoides and Sézary syndrome
28. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
29. SATB1 in Malignant T Cells
30. Risk of venous thromboembolism in patients with mycosis fungoides and parapsoriasis: A Danish nationwide population-based cohort study
31. Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
32. Using FDG-PET/CT to Detect Vascular Inflammation in Patients with Psoriasis: Where to Look? And for What??
33. Immune responses and parasitological observations induced during probiotic treatment with medicinal Trichuris suis ova in a healthy volunteer
34. Characterization of TNF-α– and IL-17A–Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ
35. Increased Prevalence of Coronary Artery Disease in Severe Psoriasis and Severe Atopic Dermatitis
36. Monitoring of animal abundance by environmental DNA — An increasingly obscure perspective: A reply to Klymus et al., 2015
37. Low-Dose (10-Gy) Total Skin Electron Beam Therapy for Cutaneous T-Cell Lymphoma: An Open Clinical Study and Pooled Data Analysis
38. Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: A Danish nationwide, population-based cohort study
39. Oligomerization of H-Ras on Membrane Surfaces
40. Single Liposomes Used to Study the Activity of Individual Transporters
41. Functional Dynamics and Allosteric Regulation of Ras Activation by SOS
42. Developing an Assay to Probe Activtion and Conformational Dynamics of β2-Adrenergic Receptor on Single Molecule Level
43. Clustering of Ras on Membrane Surfaces Independent of Lipid Anchor Effects
44. Single Molecule Study of the Processive Ras/SOS Interaction
45. CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways
46. Tumor Necrosis Factor α-Mediated Induction of Interleukin 17C in Human Keratinocytes Is Controlled by Nuclear Factor κB
47. Caspase-5 Expression Is Upregulated in Lesional Psoriatic Skin
48. Single Molecule Processivity of SOS-cat, the Catalytic Core of the Ras Gef ‘son of Sevenless’
49. The Residence Time and Processivity Study of the Ras/Sos Interaction
50. Reduced Oxazolone-Induced Skin Inflammation in MAPKAP Kinase 2 Knockout Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.